logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006 [see all tables in this series...]

Part (i) Outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use in 2006

CountryAmphetaminesMDMA and other derivatives
OutpatientInpatientOutpatientInpatient
Bulgaria11000
Czech Republic968106042
Denmark27629411
Ireland2377320
Greece0251
France8321934
Italy65198
Cyprus00121
Latvia09100
Lithuania00
Luxembourg(2)1171
Hungary56012128661
Malta019
Netherlands56383
Austria7216284
Romania65
Slovakia18916232
Finland33624634
Sweden581100336
United Kingdom4047567293
Turkey1107

Notes:

 The number of treatment clients in each country is listed in Table TDI-7.   

 See also 'General notes for interpreting data’ on the Explanatory notes and help page.   

Sources:

 Reitox national reports 2007 — Standard table 3. See Table TDI-1 for details on sources. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008